| | Class 2 Device Recall Boston Scientific |  |
| Date Initiated by Firm | December 03, 2025 |
| Date Posted | January 09, 2026 |
| Recall Status1 |
Open3, Classified |
| Recall Number | Z-1042-2026 |
| Recall Event ID |
98149 |
| 510(K)Number | K111295 |
| Product Classification |
Catheter, angioplasty, peripheral, transluminal - Product Code LIT
|
| Product | Boston Scientific Coyote OVER-THE-WIRE PTA Balloon Dilation Catheter, 4F,
1) 2.5mm x120mm, 150 cm, UPM/Model No. REF H74939186251210;
2) 3.5mm x120mm, 150 cm, UPM/Model No. REF H74939186351210;
Catheter, Angioplasty, Peripheral, Transluminal |
| Code Information |
1) GTIN 08714729796527, Batch Number 37370117, exp. 3-Sept-28;
2) GTIN 08714729796756, Batch Number 37416646, exp. 9-Sept-28 |
| FEI Number |
3002095335
|
Recalling Firm/ Manufacturer |
Boston Scientific Corporation 1 Scimed Pl Maple Grove MN 55311-1565
|
| For Additional Information Contact | Clara Johnson 763-494-1133 |
Manufacturer Reason for Recall | Boston Scientific is initiating the removal of certain batches of Coyote" Over-the-Wire (OTW) Percutaneous Transluminal Angioplasty (PTA) Balloon Dilatation Catheter devices due to the potential for inflation/deflation difficulty during use in the peripheral vasculature. An internal investigation found that a manufacturing process variation resulted in catheters that may not properly inflate/deflate. This was limited to Coyote OTW batches manufactured from 12Sep2025 through 13Oct2025. The processing variation has since been addressed. No other material numbers or batches are impacted by this removal. |
FDA Determined Cause 2 | Process change control |
| Action | Boston Scientific issued an Urgent Medical Device Removal notice to its consignees on 12/3/2025 by letter delivered via a courier service. The notice explained the issue, clinical impact to the patient, and requested the following actions:
"Instructions:
1. Further distribution or use of any remaining devices (Attachment 1) affected by this
removal should cease immediately.
Do NOT use affected devices and remove those devices from your facility s inventory. Segregate
the units in a secure place until they can be returned to Boston Scientific.
2. Immediately post this information in a visible location near the affected devices to ensure it is
readily accessible to all handlers and users of the device.
3. Forward this notice to any healthcare professional from your organization and to any facilities
where affected devices have been transferred, including hospitals or sites within your network.
If you are a distributor, this notice must be forwarded to your customers to ensure notification of
this device removal is carried out to the end-user level.
4. Complete and return the enclosed Reply Verification Tracking Form per the enclosed
instructions on page four.
5. Return affected devices."
For questions regarding this communication, please contact your local Boston Scientific
representative. |
| Quantity in Commerce | 21 units |
| Distribution | US Nationwide distribution in the states of MA, WV, OH, CA, MN, NY, VA, IL TX, FL, IL. |
| Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 The manufacturer has initiated the recall and not all products have been corrected or removed. This record will be updated as the status changes.
|
| 510(K) Database | 510(K)s with Product Code = LIT
|
|
|
|